Development of monoclonal antibodies that specifically interact with necrotic lymphoma cells

Microbiology and Immunology

Volumn 55, Issue 5, 2011, Pages 373-377

  Wakasa, Kentaro ^a   Shime, Hiroaki ^a,b   Kurita Taniguchi, Mitsue ^b   Matsumoto, Misako ^a,b   Imamura, Masahiro ^a   Seya, Tsukasa ^a,b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Medical Center for Cancer   (Japan)

Author keywords

Inflammation; Monoclonal antibody; Necrotic cell death; Pattern recognition receptors

Indexed keywords

CELL PROTEIN; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL DEATH; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOMA CELL; MOUSE; NECROTIC LYMPHOMA CELL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOMA; MEMBRANE PROTEINS; NECROSIS;

EID: 79955146440     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00319.x     Document Type: Article

References (17)

1. Kono H., Rock K.L. (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-89.
2. Seong S.Y., Matzinger P. (2004) Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4: 469-78.
3. Shi Y., Evans J.E., Rock K.L. (2003) Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-21.
4. Yanai H., Ban T., Wang Z., Choi M.K., Kawamura T., Negishi H., Nakasato M., Lu Y., Hangai S., Koshiba R., Savitsky D., Ronfani L., Akira S., Bianchi M.E., Honda K., Tamura T., Kodama T., Taniguchi T. (2009) HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature 462: 99-103.
5. Srikrishna G., Freeze H.H. (2009) Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11: 615-28.
6. Sato S., St-Pierre C., Bhaumik P., Nieminen J. (2009) Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230: 172-87.
7. Du F., Nakamura Y., Tan T.L., Lee P., Lee R., Yu B., Jamora C. (2010) Expression of snail in epidermal keratinocytes promotes cutaneous inflammation and hyperplasia conducive to tumor formation. Cancer Res 70: 10080-9.
8. Rees R.F., Gewurz H., Siegel J.N., Coon J., Potempa L.A. (1988) Expression of a C-reactive protein neoantigen (neo-CRP) in inflamed rabbit liver and muscle. Clin Immunol Immunopathol 48: 95-107.
9. Gabrilovich D.I., Nagaraj S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-74.
10. Hara T., Matsumoto M., Tsuji S., Nagasawa S., Masaoka T., Kodama K., Horai T., Sukuma T., Seya T. (1996) Enhanced opsonization of drug-induced apoptotic cells of a human adenocarcinoma cell line by homologous complement activation. Immunobiol 196: 491-503.
11. Nusbaum P., Lainé C., Seveau S., Lesavre P., Halbwachs-Mecarelli L. (2004) Early membrane events in polymorphonuclear cell (PMN) apoptosis: membrane blebbing and vesicle release, CD43 and CD16 down-regulation and phosphatidylserine externalization. Biochem Soc Trans 32(Pt 3): 477-9.
12. Hoffman T., Hirata F., Bougnoux P., Fraser B.A., Goldfarb R.H., Herberman R.B., Axelrod J. (1981) Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proc Natl Acad Sci U S A 78: 3839-43.
13. Schulz O., Diebold S.S., Chen M., Näslund T.I., Nolte M.A., Alexopoulou L., Azuma Y.T., Flavell R.A., Liljeström P., Reis e Sousa C. (2005) Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 433: 887-92.
14. Chen C.J., Kono H., Golenbock D., Reed G., Akira S., Rock K.L. (2007) Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 13: 851-6.
15. Killeen S.D., Wang J.H., Andrews E.J., Redmond H.P. (2006) Exploitation of the Toll-like receptor system in cancer: a doubled-edged sword? Br J Cancer 95: 247-52.
16. Conroy H., Marshall N.A., Mills K.H. (2008) TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 27: 168-80.
17. Chen Y., Khanna S., Goodyear C.S., Park Y.B., Raz E., Thiel S., Grönwall C., Vas J., Boyle D.L., Corr M., Kono D.H., Silverman G.J. (2009) Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J Immunol 183: 1346-59.